Preeclampsia is a leading cause of maternal morbidity and mortality worldwide. The risk of death is ~300-fold higher in LMIC where the disease is less likely recognized early enough for transfer to facilities adequately equipped for treatment. The recurring barrier has been the lack of preeclampsia-specific diagnostic tests practically suitable for LMIC. Our proposal is for in scale-up and in country implementation of the Congo Red Test, a novel diagnostic test for preeclampsia based on urine congophilia.